Grown Rogue International (GRUSF) Accounts Payables (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Accounts Payables of $2.7 million for Q1 2026, up 55.31% year-over-year from $1.8 million in Q1 2025, and up 116.36% quarter-over-quarter from $1.3 million in Q4 2025.
Grown Rogue International (GRUSF) Accounts Payables (2009 - 2026) Analysis & Trends
Grown Rogue International's Accounts Payables history runs 18 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 55.31% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (up 55.31% YoY), while the FY2025 annual figure was $1.3 million, down 53.08% from the prior year.
- Accounts Payables for Q1 2026 stood at $2.7 million, up from $1.3 million in the prior quarter.
- The five-year high for Accounts Payables was $1981.8 billion in Q3 2025, with the low at $114351.8 in Q4 2023.
- The 5-year median for Accounts Payables is $1.4 million (2025), against an average of $141.6 billion.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables sank 69.78% in 2023, then surged 127568895.65% in 2025.
- Grown Rogue International's Accounts Payables stood at $464043.3 in 2022, then tumbled by 75.36% to $114351.8 in 2023, then advanced by 8.17% to $123695.2 in 2024, then soared by 920.67% to $1.3 million in 2025, then soared by 116.36% to $2.7 million in 2026.
- Business Quant data shows GRUSF's Accounts Payables at $2.7 million in Q1 2026, $1.3 million in Q4 2025, and $1981.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Grown Rogue International | 116.22 Mn | 104.68 Mn | 5.37 Mn | 2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.54 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1,981.79 Bn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 123,695.15 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 340,523.59 |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 114,351.76 |
| Oct 31, 2023 | 140,248.48 |
| Jul 31, 2023 | 1.29 Mn |
| Jan 31, 2023 | 1.66 Mn |
| Oct 31, 2022 | 464,043.33 |
| Oct 31, 2021 | -234,531.65 |
| Apr 30, 2021 | 1.10 Mn |
| Jan 31, 2021 | 1.28 Mn |
| Oct 31, 2020 | 45,000.00 |
| Jul 31, 2020 | 1.02 Mn |